Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
56.50
-1.23 (-2.13%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Structure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Net Income
-141.2-122.53-89.62-51.32-38.05
Upgrade
Depreciation & Amortization
1.6810.320.280.07
Upgrade
Other Amortization
----0.05
Upgrade
Loss (Gain) From Sale of Assets
-10.25----
Upgrade
Loss (Gain) From Sale of Investments
-15.59-18.47-5.98-0.910.03
Upgrade
Stock-Based Compensation
28.9918.798.192.511.49
Upgrade
Other Operating Activities
2.211.60.630.350.19
Upgrade
Change in Accounts Payable
4.773.31-0.862.151.9
Upgrade
Change in Other Net Operating Assets
-92.81-0.347.830.822.17
Upgrade
Operating Cash Flow
-222.2-116.64-79.49-46.12-32.16
Upgrade
Capital Expenditures
-3.61-1.29-2.17-0.16-1.21
Upgrade
Sale of Property, Plant & Equipment
10.25----
Upgrade
Investment in Securities
83.16-357.62-266.18-61.9519.07
Upgrade
Investing Cash Flow
89.8-358.91-268.34-62.1117.86
Upgrade
Issuance of Common Stock
765.15517.06473.10.030.01
Upgrade
Repurchase of Common Stock
-0.62---0.01-
Upgrade
Other Financing Activities
-2.02-1.8-21.57-2.513.24
Upgrade
Financing Cash Flow
762.52515.26451.5329.01103.25
Upgrade
Net Cash Flow
630.1139.72103.7-79.2188.95
Upgrade
Free Cash Flow
-225.81-117.93-81.66-46.28-33.37
Upgrade
Free Cash Flow Per Share
-3.81-2.24-2.22-14.48-12.30
Upgrade
Levered Free Cash Flow
-180.03-70.78-51.38-26.08-18.79
Upgrade
Unlevered Free Cash Flow
-180.03-70.78-51.38-26.08-18.76
Upgrade
Change in Working Capital
-88.042.966.972.974.06
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.